Chelating anticoagulants reduce plasma doxycycline measurements: implications for doxy PEP monitoring

Authors

Institutions

Publication Details

Journal
Expert Review of Clinical Pharmacology
Published
2026-02-01
DOI
https://doi.org/10.1080/17512433.2026.2632931
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chelating anticoagulants reduce plasma doxycycline measurements: implications for doxy PEP monitoring

Tiancheng Edwards, Christopher Conway-Washington, Colleen F. Kelley, Jeannette A Dienhart et al.
Expert Review of Clinical Pharmacology
Atrial Fibrillation Management and Outcomes
article

Chelating anticoagulants reduce plasma doxycycline measurements: implications for doxy PEP monitoring

Tiancheng Edwards, Christopher Conway-Washington, Colleen F. Kelley, Jeannette A Dienhart, Jeffrey Fountain, Michele B Daly, Chuong Dinh, Micah Spandau, Richard Haaland
article en

Abstract

No abstract available for this paper.
Expert Review of Clinical PharmacologyVol. 19(2)
Emory University (US), ARES (United States)
Openalex Percentile: Top 56%
Atrial Fibrillation Management and Outcomes
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.